| PERIOD ENDING | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | 30-Sep-07 | | Total Revenue | 2,398,000 | 2,753,000 | 2,775,000 | 2,875,000 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 2,398,000 | 2,753,000 | 2,775,000 | 2,875,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,592,000 | 2,274,000 | 3,358,000 | 1,708,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 209,000 | 203,000 | 209,000 | 202,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 597,000 | 276,000 | (792,000) | 965,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 597,000 | 276,000 | (792,000) | 965,000 | | Interest Expense | 775,000 | 112,000 | (1,041,000) | 515,000 | | Income Before Tax | (178,000) | 164,000 | 249,000 | 450,000 | | Income Tax Expense | (69,000) | 48,000 | 69,000 | 111,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (109,000) | 116,000 | 180,000 | 339,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| (2,000) |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (109,000) | 116,000 | 178,000 | 339,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($109,000) | $116,000 | $178,000 | $339,000 |
|
1.49% Nasdaq 
0.27%
Income Statement
